Cathie Wood’s ARK Invest Buys Over 850,000 Shares of Pacific Bio
A couple of Cathie Wood's ARK Invest funds bought over 850,000 shares of Pacific Bio on August 2.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 850,000 shares of Pacific Biosciences of California Inc. (NASDAQ: PACB) altogether on Monday, as the prices of these ETFs were up less than 1% in Monday’s session. These funds are up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 96,000 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 756,850 shares. At Monday’s closing price, this would have valued these purchases at roughly $26.6 million altogether. This is only a small fraction of the total holdings. ARKG is up roughly 59% in the past year and ARKK is up 53%.
Check out all of ARK Invest’s buys for Monday:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | ETSY | Etsy | 64,213 |
| ARKG | VERV | Verve Therapeutics | 94,600 |
| ARKG | SURF | Surface Oncology | 14,000 |
| ARKG | SMFR | Sema4 | 551,578 |
| ARKG | SGFY | Signify Health | 102,356 |
| ARKG | RPTX | Repare Therapeutics | 5,897 |
| ARKG | QSI | Quantum-Si | 70,000 |
| ARKG | PACB | Pacific Biosciences of California | 96,000 |
| ARKG | FATE | Fate Therapeutics | 27,556 |
| ARKG | CMIIU | CM Life Sciences II | 5,000 |
| ARKG | EDIT | Editas Medicine | 30,356 |
| ARKG | MASS | 908 Devices | 10,671 |
| ARKK | VCYT | Veracyte | 11,405 |
| ARKK | PD | PagerDuty | 167,000 |
| ARKK | PACB | Pacific Biosciences of California | 756,850 |
| ARKK | CRSP | CRISPR Therapeutics | 55,000 |
| ARKK | BEAM | Beam Therapeutics | 81,497 |
| ARKQ | MKFG | Markforged | 18,200 |
| ARKQ | PATH | UiPath | 283,325 |
| ARKQ | SPFR | Jaws Spitfire Acquisition | 74,000 |
| ARKQ | U | Unity Software | 166,740 |
| ARKQ | LMT | Lockheed Martin | 57,202 |
| ARKQ | IRDM | Iridium Communications | 202,159 |
| ARKQ | AVAV | AeroVironment | 15,267 |
| ARKW | VUZI | Vuzix | 99,712 |
| ARKW | PD | PagerDuty | 43,000 |
| ARKW | KVSB | Khosla Venture Acquisition II | 90,000 |
| ARKW | TWLO | Twilio | 31,572 |
| ARKW | ETSY | Etsy | 61,144 |
| ARKW | CND | Concord Acquisition | 35,000 |
| ARKX | AMZN | Amazon.com | 373 |
| ARKX | LMT | Lockheed Martin | 5,784 |
| ARKX | SPFR | Jaws Spitfire Acquisition | 16,000 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
